ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0974

Role of NR4A Nuclear Receptor Family in RA Synovial Ectopic Lymphoid Neogenesis Revealed by Single Cell Profiling

Nida Meednu1, Fan Zhang2, Katherine Escalera-Rivera1, Elisa Corsiero3, Edoardo Prediletto3, Michele Bombardieri4, Edward DiCarlo5, Dana Orange6, Susan Goodman7, Laura Donlin8, Soumya Raychaudhuri2, Costantino Pitzalis4, Andrew McDavid1 and Jennifer Anolik1, 1University of Rochester Medical center, Rochester, NY, 2Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, 3Queen Mary University of London, London, England, United Kingdom, 4Queen Mary University of London, London, United Kingdom, 5Hospital for Special Surgery, New York, 6Rockefeller University, New York, 7Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 8Hospital for Special Surgery, Weill Cornell Medicine, New York

Meeting: ACR Convergence 2020

Keywords: B-Lymphocyte, Bioinformatics, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 7, 2020

Title: RA – Etiology & Pathogenesis (0970–0974)

Session Type: Abstract Session

Session Time: 3:00PM-3:50PM

Background/Purpose: Ectopic lymphoid structures (ELS) have been observed in synovial tissue of rheumatoid arthritis (RA) patients but their functional relevance in the disease remains unclear. Additionally, little is known about B cell activation pathways during ectopic lymphoid neogenesis (ELN). In this study, we utilized single cell RNA sequencing coupled with B cell repertoire sequencing to characterize B cell subsets that may play a role in ELN in RA synovial tissue and support local B cell activation and development of autoreactive plasma cells.

Methods: Synovial tissue was selected based on the presence of lymphocytic infiltrates by histology (n=4 RA patients). Tissue was disaggregated using protocols established by the Accelerating Medicines Partnership (AMP) consortium. scRNA-seq was performed on sorted tissue B cells using the 10x genomic platform with poly-A selected, 5’ initiated expression and V(D)J libraries generated from each single cell. Transcriptomic clusters were compared using supervised classification techniques to AMP phase I RA synovial B cells (n=10), SLE kidney B cells, and blood B cells. Combined single cell repertoire/RNA sequencing from an additional 13 RA synovial samples and 10 matched blood B cells are currently under analysis in AMP phase II. In vitro studies were conducted for elucidation of signals promoting in situ B cell activation, with NR4A detected by qPCR and flow cytometry.

Results: Using single cell RNA sequencing analysis, we identified a unique B cell subset in the RA synovium characterized by high expression of NR4A1-3, a family of orphan nuclear receptors (NUR77, NURR1, and NOR1) that are induced by acute and chronic antigen stimulation in lymphocytes and function as ligand-independent transcription factors. The NR4A+ B cell cluster showed evidence of somatic hypermutation (SHM) and class-switched recombination based on repertoire analysis.  The rate of SHM was positively correlated with NR4A1 and NR4A2 gene expression and inversely correlated with IGHD gene expression. Gene Set Enrichment Analysis revealed that the NR4A+ cluster has a transcriptomic profile between naïve and germinal center (GC) B cells sorted from tonsil and differentially expressed genes characteristic of GC centrocytes including CD83 and GPR183. In SLE kidney, and peripheral blood B cells, NR4A+ B cells were reduced to 0.7% and 1.5% abundance, respectively, compared to >40% abundance in synovial tissue from AMP phase I and the 10X platform (p< 0.001 under logistic mixed models). NRA4 was upregulated at both the RNA and protein level upon activation through the B cell receptor in vitro. NR4A1 protein was expressed spontaneously in RA tissue B cells by flow cytometric and histologic analysis.

Conclusion: Our data suggest a dynamic progression of B cell activation in RA synovial ectopic lymphoid structures, with NR4A a potential read-out of chronic antigen activation and local adaptive immune responses.


Disclosure: N. Meednu, None; F. Zhang, None; K. Escalera-Rivera, None; E. Corsiero, None; E. Prediletto, None; M. Bombardieri, None; E. DiCarlo, None; D. Orange, None; S. Goodman, Pfizer, 1, Novartis, 1, UCB, 1, regenosine, 1, 2, Horizon, 1; L. Donlin, Stryker, 1, 2; S. Raychaudhuri, None; C. Pitzalis, None; A. McDavid, None; J. Anolik, None.

To cite this abstract in AMA style:

Meednu N, Zhang F, Escalera-Rivera K, Corsiero E, Prediletto E, Bombardieri M, DiCarlo E, Orange D, Goodman S, Donlin L, Raychaudhuri S, Pitzalis C, McDavid A, Anolik J. Role of NR4A Nuclear Receptor Family in RA Synovial Ectopic Lymphoid Neogenesis Revealed by Single Cell Profiling [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/role-of-nr4a-nuclear-receptor-family-in-ra-synovial-ectopic-lymphoid-neogenesis-revealed-by-single-cell-profiling/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/role-of-nr4a-nuclear-receptor-family-in-ra-synovial-ectopic-lymphoid-neogenesis-revealed-by-single-cell-profiling/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology